ArticleJournal of hepatocellular carcinoma2025
Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients.
Chung-Wei Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.